Kirsty (previously Kixelle)


insulin aspart

This medicine is authorised for use in the European Union.


Kirsty is a medicine used to control blood glucose (sugar) levels in patients from one year of age who have diabetes.

Kirsty is a ‘biosimilar medicine’. This means that Kirsty is highly similar to another biological medicine (the ‘reference medicine’) that is already authorised in the EU. The reference medicine for Kirsty is NovoRapid. For more information on biosimilar medicines, see here.

Kirsty contains the active substance insulin aspart.

This EPAR was last updated on 01/12/2023

Authorisation details

Product details
Kirsty (previously Kixelle)
Agency product number
Active substance
insulin aspart
International non-proprietary name (INN) or common name
insulin aspart
Therapeutic area (MeSH)
Diabetes Mellitus
Anatomical therapeutic chemical (ATC) code
Additional monitoringAdditional monitoring

This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines. For more information, see Medicines under additional monitoring.


This is a biosimilar medicine, which is a biological medicine highly similar to another already approved biological medicine called the ‘reference medicine’. For more information, see Biosimilar medicines.

Publication details
Marketing-authorisation holder
Biosimilar Collaborations Ireland Limited
Date of issue of marketing authorisation valid throughout the European Union
Contact address

Unit 35/36
Grange Parade,
Baldoyle Industrial Estate
Dublin 13
D13 R20R

Product information

30/11/2023 Kirsty (previously Kixelle) - EMEA/H/C/004965 - IAIN/0013

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Drugs used in diabetes

Therapeutic indication

Kirsty is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Assessment history

How useful was this page?

Add your rating
1 rating